Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies
Authors
Keywords
cancer, checkpoint inhibitor, immunotherapy, immunostimulatory, immune-related adverse events, nonclinical, safety
Journal
AAPS Journal
Volume 20, Issue 2, Pages -
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2018-02-08
DOI
10.1208/s12248-017-0184-3

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.